Free cookie consent management tool by TermsFeed

Our Portfolio

Home > Our Portfolio 

HTG Molecular

High Throughput Genomics

HTG Molecular Diagnostics (HTG) was founded in 1997 with the mission to develop a universal molecular biology-based platform to improve the pharmaceutical drug discovery process. Since that time, HTG has expanded the utility of qNPA™ technology into the fields of gene expression profiling, Translational Medicine and Diagnostic applications, and the measurement of miRNA.